Last year marked the first time in Pfizer’s 175-year history that the drugmaker shelled out the requisite millions for ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...
Walmart’s latest brand and logo update has left some social media users baffled. On Jan. 13, the company announced in a press release on its website that it was launching a “comprehensive ...
Department ZYDUS PFIZER Job posted on Jan 07, 2025 Employment type P-P8-Probationer-HO Executive Designation :Assistant Manager / Deputy Manager - Production - QMS Department : Quality Assurances ...
U.S. drugmaker Pfizer PFE.N is going “all in” to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Executive Officer Albert Bourla said at the JPMorgan ...
Want to brand your business without breaking the bank? The best free logo maker will be an essential tool in your marketing kit - and after testing these completely free logo designers ...
We've been getting creative with the best logo makers for branding your business online. It's difficult to understate the importance of good logo design - it's the quickest way for customers and ...
Zydus Lifesciences Ltd. said on Wednesday that the US Food and Drug Administration granted its underdevelopment drug Usnoflast the orphan drug designation, according to an exchange filing on Wednesday ...
The Pfizer Foundation has provided $15 million investment to a three-year initiative to improve the lives of women with breast cancer in Rwanda, Ghana, and Tanzania. The Grant funding will be provided ...
PF-07976016 is under clinical development by Pfizer and currently in Phase I for Obesity. According to GlobalData, Phase I drugs for Obesity have a 59% phase transition success rate (PTSR) indication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results